Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Rifampicin
Sigma Pharmaceuticals Plc
J04AB02
Rifampicin
300mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010900
RIFADIN 300MG CAPSULES rifampicin PACKAGE LEAFLET: INFORMATION FOR THE USER IN PARTICULAR, DO NOT TAKE THIS MEDICINE, AND TELL YOUR DOCTOR, IF YOU ARE TAKING: • Saquinavir or ritonavir used for HIV infection THE FOLLOWING MEDICINES CAN MAKE RIFADIN 300MG CAPSULES WORK LESS WELL: • Antacids used for indigestion. Take Rifadin 300mg Capsules at least 1 hour before taking antacids • Other medicines used for TB such as P-aminosalicyclic acid (PAS). PAS and Rifadin 300mg Capsules should be taken at least 8 hours apart TELL YOUR DOCTOR IF YOU ARE TAKING ANY OF THE FOLLOWING MEDICINES: HEART AND BLOOD MEDICINES • Medicines for high blood pressure • Medicines for heart problems or to control your heartbeat • Medicines used to thin the blood such as warfarin • Medicines used to lower cholesterol • Water tablets (diuretics) such as eplerenone MENTAL HEALTH, EPILEPSY AND MOTOR NEURONE MEDICINES • Medicines for thought disorders known as ‘antipsychotics’ such as haloperidol • Medicines to calm or reduce anxiety (hypnotics, anxiolytics) • Medicines to help you sleep (barbiturates) • Medicines used for epilepsy such as phenytoin • Some medicines used for depression such as amitriptyline and nortriptyline • Riluzole - used for motor neurone disease MEDICINES FOR INFECTIONS AND THE IMMUNE SYSTEM • Some medicines used for viral infections such as indinavir, efavirenz, amprenavir, nelfinavir, atazanavir, lopinavir, neviparine, daclatasvir, simeprevir, sofosbuvir and telaprevir • Medicines used for fungal infections • Medicines used for bacterial infections (antibiotics) • Medicines used for lowering your immune system such as ciclosporin, sirolimus and tacrolimus • Praziquantel - used for tapeworm infections • Atovaquone - used for pneumonia HORMONE AND CANCER MEDICINES • Some hormone medicines (estrogen, systemic hormones, progestogens) used for contraception or some types of cancer such as ethinyloestradiol, levonorgestrel or dydrogesterone • Some hormone medicines (anti-estrogens) Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Rifadin 300mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Rifampicin Ph Eur 300 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, hard. The gelatin capsule is opaque, composed of a scarlet body and cap, marked R-300. 4.1 THERAPEUTIC INDICATIONS Indications for use Tuberculosis: In combination with other active anti-tuberculosis drugs in the treatment of all forms of tuberculosis, including fresh, advanced, chronic and drug-resistant cases. Rifadin is also effective against most atypical strains of Mycobacteria. Leprosy: In combination with at least one other active anti-leprosy drug in the management of multibacillary and paucibacillary leprosy to effect conversion of the infectious state to a non-infectious state. Other Infections: In the treatment of Brucellosis, Legionnaires Disease, and serious staphylococcal infections. To prevent emergence of resistant strains of the infecting organisms, Rifadin should be used in combination with another antibiotic appropriate for the infection. Prophylaxis of meningococcal meningitis: For the treatment of asymptomatic carriers of N. meningitidis to eliminate meningococci from the nasopharynx. Haemophilus influenzae: For the treatment of asymptomatic carriers of H.influenzae and as chemoprophylaxis of exposed children, 4 years of age or younger. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Recommended Dosage For oral administration The daily dose of Rifadin, calculated from the patient’s body weight, should preferably be taken at least 30 minutes before a meal or 2 hours after a meal to ensure rapid and complete absorption. Tuberculosis: Rifadin should be given with other effective anti-tuberculosis drugs to prevent the possible emergence of rifampicin-resistant strains of Mycobacteria. _Adults_: The recommended single daily dose in tuberculosis is 8-12 mg/kg. _Usual Daily dose_: Patients weighing less than 50 kg - 450 mg. Patients weighing 50 kg or more – 600 mg. _Ch Read the complete document